The project forms part of GSK's £400 million investment and reinforces Cambridge's position as a global life sciences hub.
CRE Herald
Unlock Unlimited CRE Intelligence
Market analysis, deal insights, and sector research trusted by fund managers, asset managers, and senior executives.
Already s subscriber? Log in to unlock this content
